As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Biopharmaceuticals Market: By Product Type: Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Others; By Therapeutic Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Biopharmaceuticals Market Outlook

The global biopharmaceuticals market stood at a value of around USD 325.2 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 7.6% to reach USD 502.4 billion by 2026.

 

Global Biopharmaceutical Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Monoclonal Antibodies Segment Predicted to Hold a Significant Market Share over the Forecast Period

Based on product type, monoclonal antibodies (MAbs) are expected to hold a significant share in the biopharmaceuticals industry during the forecast period, owing to their increased therapeutic applications to treat chronic disorders and in the field of oncology. They are developed artificially in laboratories using biotechnological tools. Monoclonal antibodies are used to cure different types of autoimmune conditions, infectious diseases, and cancer. Their lower toxicity and enhanced safety compared to chemotherapy drugs have proven to improve patient survival rates and reduce adverse side effects.  These factors are expected to aid the growth of the segment in the coming years.

 

North America Secured the Largest Market Share and is Anticipated to Retain its Dominance in the Forecast Period

Geographically, North America is anticipated to dominate the global market for biopharmaceuticals during the forecast period. The increasing investments in research and development activities and the growing burden of chronic disease are the key factors driving the biopharmaceuticals industry growth in North America. Meanwhile, the biopharmaceuticals industry is expected to grow at a significant CAGR in the Asia Pacific region during the forecast period due to an increase in the number of people suffering from diabetes and other chronic diseases and the increased availability of biopharmaceutical products in the region.

 

 

 

Biopharmaceuticals: Industry Definition and Segmentation

Biopharmaceuticals are medicinal products containing proteins, sugars, nucleic acid, tissues, and living cells derived from various biological sources such as animals, microorganisms, and humans. In 1982, recombinant human insulin (Humulin) made from specially modified bacteria was the first biopharmaceutical approved by the food and drug administration (FDA) for human therapeutic uses and marketing. Following the success of Humulin, various types of biopharmaceuticals have been derived from recombinant DNA such as whole blood, vaccine, antigens, hormones, immunosera, enzymes, cytokines, monoclonal antibodies, allergenic, and gene therapies, among others.

 

Global Biopharmaceutical Market By Therapeutic Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product type, the industry can be segmented into:

  • Monoclonal Antibodies 
    • Anti-Cancer Monoclonal Antibodies 
    • Anti-Inflammatory Monoclonal Antibodies 
    • Others
  • Recombinant Growth Factors
    • Erythropoietin 
    • Granulocyte Colony Stimulating Factor 
  • Purified Proteins  
    • Leukemia Inhibitory Factor (LIF) 
    • P53 Protein 
    • P38 Protein 
    • Others
  • Recombinant Proteins
    • Serum Albumin 
    • Amyloid Protein 
    • Defensin 
    • Transferrin 
  • Recombinant Hormones 
    • Recombinant Human Growth Hormones 
    • Recombinant Insulin 
    • Others 
  • Vaccines 
    • Recombinant Vaccines 
      • Cancer Vaccines  
      • Malaria Vaccines  
      • Ebola Vaccine  
      • Hepatitis B Vaccine  
      • Tetanus Vaccine  
      • Diphtheria Vaccine  
      • Cholera Vaccines  
      • Others
    • Conventional Vaccines
      • Polio Vaccine  
      • Pox Vaccine  
      • Others
  • Recombinant Enzymes  
    • Enterokinase 
    • Cyclase 
    • Caspase 
    • Cathepsin
  • Cell and Gene Therapies   
    • Allogenic Products 
    • Autologous Products 
    • Acellular Products  
  • Synthetic Immunomodulators  
    • Cytokines, Interferons, and Interleukins
  • Others

Based on therapeutic application, the industry can be divided into:

  • Oncology 
  • Inflammatory and Infectious Diseases
  • Autoimmune Disorders
  • Metabolic Disorders
  • Hormonal Disorders
  • Cardiovascular Diseases
  • Neurological Diseases
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Biopharmaceutical Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increase in Research and Development Activities to Bolster the Growth of the Global Biopharmaceuticals Industry

The biopharmaceuticals industry has been growing considerably for the last few years. The biopharmaceutical products are widely used in the treatment of diabetes, cancer, rheumatoid arthritis, and psoriasis. Extensive use of biopharmaceuticals in the treatment of chronic diseases, such as diabetes, cancer, and heart diseases, is a key factor expected to propel the market growth during the forecast period. Moreover, the growing research and development activities by the major pharmaceutical companies and the rapid advancements in genetic engineering are the key trends in the market, which are expected to further propel the biopharmaceuticals industry.

 

 

 

Key Industry Players in the Global Biopharmaceuticals Market

The report gives a detailed analysis of the following key players in the global biopharmaceuticals market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Amgen Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Therapeutic Application, Region
Breakup by Product Type Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, Others
Breakup by Therapeutic Application Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Amgen Inc., AbbVie Inc., Bristol-Myers Squibb Company., Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc., GlaxoSmithKline plc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Biopharmaceuticals Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Biopharmaceuticals Historical Market (2016-2020) 
    8.3    Global Biopharmaceuticals Market Forecast (2021-2026)
    8.4    Global Biopharmaceuticals Market by Product Type
        8.4.1    Monoclonal Antibodies
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Anti-Cancer Monoclonal Antibodies
                8.4.1.4.2    Anti-Inflammatory Monoclonal Antibodies
                8.4.1.4.3    Others
        8.4.2    Recombinant Growth Factors
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Erythropoietin
                8.4.2.4.2    Granulocyte Colony Stimulating Factor
        8.4.3    Purified Proteins
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    Leukemia Inhibitory Factor (LIF)
                8.4.3.4.2    P53 Protein
                8.4.3.4.3    P38 Protein
                8.4.3.4.4    Others
        8.4.4    Recombinant Proteins
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
            8.4.4.4    Breakup by Type
                8.4.4.4.1    Serum Albumin
                8.4.4.4.2    Amyloid Protein
                8.4.4.4.3    Defensin
                8.4.4.4.4    Transferrin
        8.4.5    Recombinant Hormones
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
            8.4.5.4    Breakup by Type
                8.4.5.4.1    Recombinant Human Growth Hormones
                8.4.5.4.2    Recombinant Insulin
                8.4.5.4.3    Others
        8.4.6    Vaccines
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
            8.4.6.4    Breakup by Type
                8.4.6.4.1    Recombinant Vaccines
                8.4.6.4.2    Breakup by Type
                    8.4.6.4.2.1    Cancer Vaccines 
                    8.4.6.4.2.2    Malaria Vaccines 
                    8.4.6.4.2.3    Ebola Vaccine 
                    8.4.6.4.2.4    Hepatitis B Vaccine 
                    8.4.6.4.2.5    Tetanus Vaccine 
                    8.4.6.4.2.6    Diphtheria Vaccine 
                    8.4.6.4.2.7    Cholera Vaccines 
                    8.4.6.4.2.8    Others
                8.4.6.4.3    Conventional Vaccines
                8.4.6.4.4    Breakup by Type
                    8.4.6.4.4.1    Polio Vaccine 
                    8.4.6.4.4.2    Pox Vaccine 
                    8.4.6.4.4.3    Others
        8.4.7    Recombinant Enzymes 
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2016-2020)
            8.4.7.3    Forecast Trend (2021-2026)
            8.4.7.4    Breakup by Type
                8.4.7.4.1    Enterokinase
                8.4.7.4.2    Cyclase
                8.4.7.4.3    Caspase
                8.4.7.4.4    Cathepsin
        8.4.8    Cell and Gene Therapies
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2016-2020)
            8.4.8.3    Forecast Trend (2021-2026) 
            8.4.8.4    Breakup by Type
                8.4.8.4.1    Allogenic Products
                8.4.8.4.2    Autologous Products
                8.4.8.4.3    Acellular Products
        8.4.9    Synthetic Immunomodulators
            8.4.9.1    Market Share
            8.4.9.2    Historical Trend (2016-2020)
            8.4.9.3    Forecast Trend (2021-2026) 
            8.4.9.4    Breakup by Type
                8.4.9.4.1    Cytokines, Interferons, and Interleukins
        8.4.10    Others
    8.5    Global Biopharmaceuticals Market by Therapeutic Application
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Inflammatory and Infectious Diseases
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Autoimmune Disorders
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Metabolic Disorders
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Hormonal Disorders
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2016-2020)
            8.5.5.3    Forecast Trend (2021-2026)
        8.5.6    Cardiovascular Diseases
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2016-2020)
            8.5.6.3    Forecast Trend (2021-2026)
        8.5.7    Neurological Diseases
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2016-2020)
            8.5.7.3    Forecast Trend (2021-2026)
        8.5.8    Others
    8.6    Global Biopharmaceuticals Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Amgen Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    AbbVie Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Bristol-Myers Squibb Company.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Eli Lilly and Company
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Novo Nordisk A/S
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Pfizer Inc.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    GlaxoSmithKline plc.
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Biopharmaceuticals Market: Key Industry Highlights, 2016 and 2026
2.    Global Biopharmaceuticals Historical Market: Breakup by Product Type (USD Billion), 2016-2020
3.    Global Biopharmaceuticals Market Forecast: Breakup by Product Type (USD Billion), 2021-2026
4.    Global Biopharmaceuticals Historical Market: Breakup by Therapeutic Application (USD Billion), 2016-2020
5.    Global Biopharmaceuticals Market Forecast: Breakup by Therapeutic Application (USD Billion), 2021-2026
6.    Global Biopharmaceuticals Historical Market: Breakup by Region (USD Billion), 2016-2020
7.    Global Biopharmaceuticals Market Forecast: Breakup by Region (USD Billion), 2021-2026
8.    North America Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
9.    North America Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
10.    Europe Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    Europe Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Asia Pacific Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Asia Pacific Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Latin America Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Latin America Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Middle East and Africa Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Middle East and Africa Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Global Biopharmaceuticals Market Structure

Key Questions Answered in the Report

In 2020, the global biopharmaceuticals market attained a value of nearly USD 325.2 billion.

The market is projected to grow at a CAGR of 7.6% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 502.4 billion by 2026.

The increasing prevalence of chronic diseases, advancements in the medical sector, and the growing investments by the leading life sciences companies are the major factors propelling the growth of the market.

The key market trends guiding the growth of the industry include the rise in research and development activities by pharmaceutical companies and the advancements in genetic engineering.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

Monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins,  recombinant hormones, vaccines, recombinant enzymes, cell and gene therapies, and synthetic immunomodulators, among others are the significant product types in the industry.

Oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, cardiovascular diseases, and neurological diseases, among others are the significant therapeutic applications of the product.

The major players in the industry are Amgen Inc., AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc., and  GlaxoSmithKline plc., among others.

Analyst Review

The global biopharmaceuticals market attained a value of USD 325.2 billion in 2020, driven by the advancements in the medical sector and the increasing incidences of chronic diseases. Aided by the increasing research and development activities in the life sciences industry, especially after the COVID-19 outbreak, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 7.6%. The market is projected to reach USD 502.4 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product types, the biopharmaceuticals industry can be segmented into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins,  recombinant hormones, vaccines, recombinant enzymes, cell and gene therapies, and synthetic immunomodulators, among others. On the basis of therapeutic application, the industry can be segmented into oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, cardiovascular diseases, and neurological diseases, among others. The major regional markets for biopharmaceuticals are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include Amgen Inc., AbbVie Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc., and  GlaxoSmithKline plc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER